| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.28381 |
| P698 | PubMed publication ID | 23852449 |
| P50 | author | Jae Hee Cheon | Q38639123 |
| P2093 | author name string | Tae Il Kim | |
| Won Ho Kim | |||
| Chang Mo Moon | |||
| Kyoung Jin Lee | |||
| Ji-Hee Kwon | |||
| Jae Jun Park | |||
| Sung Pil Hong | |||
| Sun-Hee Oh | |||
| Ji Suk Kim | |||
| P2860 | cites work | Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 | Q24650743 |
| Phenotypic characterization of human colorectal cancer stem cells | Q24674126 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer | Q28188848 | ||
| A randomized trial of aspirin to prevent colorectal adenomas | Q28195296 | ||
| Identification of selective inhibitors of cancer stem cells by high-throughput screening | Q28255115 | ||
| Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival | Q28277824 | ||
| A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation | Q28368349 | ||
| Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) | Q28586461 | ||
| 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma | Q29615221 | ||
| Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas | Q29620630 | ||
| PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells | Q30484694 | ||
| Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen | Q31634572 | ||
| Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy | Q33344524 | ||
| Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells | Q34104156 | ||
| Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis | Q34359198 | ||
| Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission | Q34611836 | ||
| Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism. | Q34649758 | ||
| Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030. | Q35125616 | ||
| Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment | Q35148973 | ||
| The role of COX-2 in intestinal inflammation and colorectal cancer | Q35234704 | ||
| Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition | Q35415181 | ||
| Breast cancer stem cells, cytokine networks, and the tumor microenvironment | Q35571904 | ||
| Cancer immunology--analysis of host and tumor factors for personalized medicine | Q35583180 | ||
| Prostaglandin E2 promotes intestinal tumor growth via DNA methylation | Q35742739 | ||
| Human colon cancer stem cells: a new paradigm in gastrointestinal oncology | Q37186422 | ||
| Tumour-initiating cells: challenges and opportunities for anticancer drug discovery | Q37606286 | ||
| Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
| Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms | Q38036541 | ||
| NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer | Q39227342 | ||
| Symmetric division of cancer stem cells--a key mechanism in tumor growth that should be targeted in future therapeutic approaches | Q40219494 | ||
| Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. | Q40350197 | ||
| Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs | Q42551374 | ||
| The role of NF-κB and PPARγ in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors. | Q43049437 | ||
| Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo | Q43110972 | ||
| Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta | Q46123301 | ||
| CD133+CD44+ population efficiently enriches colon cancer initiating cells | Q46457938 | ||
| The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway | Q46718510 | ||
| Sulindac suppresses tumorigenesis in the Min mouse. | Q53452327 | ||
| Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. | Q54374200 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 519-529 | |
| P577 | publication date | 2013-08-07 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer | |
| P478 | volume | 134 |
| Q37687351 | A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment |
| Q54939383 | Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression. |
| Q40160860 | Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition |
| Q58796715 | Aspirin cooperates with p300 to activate the acetylation of H3K9 and promote FasL-mediated apoptosis of cancer stem-like cells in colorectal cancer |
| Q35833223 | Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer |
| Q33727848 | Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy |
| Q40352933 | Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells |
| Q46605584 | Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes |
| Q64880830 | Breast cancer stem cells and the challenges of eradication: a review of novel therapies. |
| Q36608674 | Cancer stem cell phenotype is supported by secretory phospholipase A2 in human lung cancer cells |
| Q33688897 | Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. |
| Q27026428 | Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer |
| Q35452772 | Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer |
| Q89835973 | Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers |
| Q38322466 | Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells |
| Q91672650 | Drug-induced gene expression profile changes in relation to intestinal toxicity: State-of-the-art and new approaches |
| Q92219419 | Exploring the Pharmacological Mechanism of the Herb Pair "HuangLian-GanJiang" against Colorectal Cancer Based on Network Pharmacology |
| Q38914804 | HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer |
| Q50510470 | Indomethacin sensitizes resistant transformed cells to macrophage cytotoxicity. |
| Q39032753 | Inflammation and Notch signaling: a crosstalk with opposite effects on tumorigenesis |
| Q37706766 | Metabolic enzymes: key modulators of functionality in cancer stem-like cells |
| Q64059666 | Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts |
| Q92889973 | Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy |
| Q38715916 | POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells |
| Q58554308 | PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer |
| Q36604053 | Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice |
| Q89053710 | R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells |
| Q88588314 | Role of prostanoids in gastrointestinal cancer |
| Q41441045 | Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop |
| Q39251611 | Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway |
| Q55268769 | TGF-β1 mediates the effects of aspirin on colonic tumor cell proliferation and apoptosis. |
| Q89538015 | The Association Between Inflammation, Epithelial Mesenchymal Transition and Stemness in Colorectal Carcinoma |
| Q38759894 | The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells |
| Q36183080 | The effect of prediagnostic aspirin use on the prognosis of stage III colorectal cancer |
| Q28087427 | The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism |
| Q36679858 | The hallmarks of premalignant conditions: a molecular basis for cancer prevention |
| Q35790286 | The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study |
| Q90040642 | Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness |
| Q48588772 | YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells |
Search more.